How has been the historical performance of Prism Medico?

Answer:The historical performance of Prism Medico shows significant growth in net sales over the years, increasing from 5.28 Cr in Mar'17 to 54.73 Cr in Mar'19. The total operating income followed a similar trend, rising from 5.28 Cr in Mar'17 to 54.73 Cr in Mar'19. However, the company has faced challenges with profitability, as indicated by the operating profit margin which decreased from 3.33% in Mar'18 to 0.73% in Mar'19, and the profit before tax turned negative at -0.10 Cr in Mar'19 after a positive 0.07 Cr in Mar'18. Despite these challenges, the profit after tax showed a slight recovery to 0.04 Cr in Mar'19 from a loss in the previous years. The total assets increased from 17.26 Cr in Mar'17 to 21.13 Cr in Mar'19, while total liabilities also rose from 15.80 Cr in Mar'18 to 21.13 Cr in Mar'19, indicating a growing financial base but also increasing obligations. The cash flow results indicate no cash inflow or outflow from operating, investing, or financing activities for the years reported.

Breakdown:
Prism Medico's financial performance has demonstrated a remarkable increase in net sales, which surged from 5.28 Cr in Mar'17 to 54.73 Cr in Mar'19, reflecting a strong growth trajectory. The total operating income mirrored this growth, reaching 54.73 Cr in Mar'19. However, the company struggled with profitability, as evidenced by a decline in operating profit margin from 3.33% in Mar'18 to 0.73% in Mar'19, and a negative profit before tax of -0.10 Cr in Mar'19, contrasting with a profit of 0.07 Cr in the prior year. Despite these setbacks, the profit after tax improved to 0.04 Cr in Mar'19, following losses in earlier years. On the balance sheet, total assets rose from 17.26 Cr in Mar'17 to 21.13 Cr in Mar'19, while total liabilities increased correspondingly from 15.80 Cr to 21.13 Cr, indicating a growing but leveraged financial position. The cash flow statements reveal no activity in cash flows from operations, investments, or financing, suggesting a stagnant cash position during this period.